Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 152  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
CASE REPORT
Year : 2019  |  Volume : 64  |  Issue : 5  |  Page : 400-403

Blau syndrome associated with nucleotide-binding oligomerization domain containing 2 mutation in a baby from Malaysia


1 Department of Pediatrics, Institute of Pediatric, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur 50586, Malaysia
2 Department of Research, National Skin Center, Singapore 308205, Singapore
3 Institute of Molecular and Cell Biology, A*Star, Proteos, Singapore 138673; Singapore Bioprocessing Technology Institute, Singapore 138668; Department of Pharmacology, National University of Singapore, Singapore 117660, Singapore

Correspondence Address:
Zacharias Aloysius Dwi Pramono
Department of Research, National Skin Center, 1 Mandalay Road, Singapore 308205
Singapore
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijd.IJD_44_18

Rights and Permissions

Blau syndrome (BS) is a very rare autosomal dominant juvenile inflammatory disorder caused by mutation in nucleotide-binding oligomerization domain containing 2 (NOD2). Usually, dermatitis is the first symptom that appears in the 1styear of life. About 220 BS cases with confirmed NOD2 mutation have been reported. However, the rarity and lack of awareness of the disease, especially in the regions where genetic tests are very limited, often result in late diagnosis and misdiagnosis. Here, we report a de novo BS case from Malaysia, which may be the first report from southeast Asia. PCR and DNA sequencing of peripheral blood mononuclear cells were performed to screen the entire coding region of NOD2 gene. A heterozygous c.1000C>T transition in exon 4, p. R334W, of the NOD2 gene was identified in the patient. This report further reaffirms the ubiquitousness of the disease and recurrency of p. R334W mutation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed372    
    Printed11    
    Emailed0    
    PDF Downloaded22    
    Comments [Add]    

Recommend this journal